We use cookies to customise content for your subscription and for analytics. If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
The perceived opaque market structure and comparatively unmitigated risks existing in over the counter ("OTC") derivatives trading have generated much discussion amongst regulators in the last twelve months
